Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. 2004

Helen J L Speirs, and Ksenia Katyk, and Natasha N Kumar, and Adam V Benjafield, and William Y S Wang, and Brian J Morris
Basic & Clinical Genomics Laboratory, School of Medical Sciences and Institute for Biomedical Research, The University of Sydney, Sydney, NSW 2006, Australia.

OBJECTIVE To perform association studies of polymorphisms of the potential candidate essential hypertension (HT) genes GRK4, PTP1B and HSD3B1. METHODS Subjects consisted of 168 unrelated, Caucasian essential hypertensive (HT) patients and 312 normotensive (NT) controls. Biological power was increased by ensuring subjects in each group had parents with the same blood pressure (BP) status as theirs. Three GRK4gamma variants (R65L, A142V and A486V), one HSD3B1 variant (T<---C Leu) and one PTP1B variant (1484insG) were genotyped by polymerase chain reaction and restriction enzyme digestion or by homogenous MassEXTEND Assay. RESULTS The V allele of the A486V variant of GRK4gamma, but not the R65L or A142V variants, showed an association with HT (P = 0.02). The V allele was also associated with an elevation in systolic blood pressure (SBP) (P = 0.002). Although the L65 and the V142 alleles tracked with elevation in diastolic (DBP), this was seen only in male HTs (P = 0.009; P = 0.002, respectively). Haplotype frequencies differed between the HT and NT groups, particularly for the R, V, V haplotype combination of R65L, A142V and A486V, respectively. Neither of the HSD3B1 or PTP1B variants were associated with HT. CONCLUSIONS Genetic variation in GRK4gamma was associated with HT in the subjects studied.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D005260 Female Females
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015096 3-Hydroxysteroid Dehydrogenases Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. 3-beta-Hydroxysteroid Dehydrogenase,3 Hydroxysteroid Dehydrogenases,3 beta Hydroxysteroid Dehydrogenase,Dehydrogenase, 3-beta-Hydroxysteroid,Dehydrogenases, 3 Hydroxysteroid,Dehydrogenases, 3-Hydroxysteroid,Hydroxysteroid Dehydrogenases, 3

Related Publications

Helen J L Speirs, and Ksenia Katyk, and Natasha N Kumar, and Adam V Benjafield, and William Y S Wang, and Brian J Morris
March 2002, Proceedings of the National Academy of Sciences of the United States of America,
Helen J L Speirs, and Ksenia Katyk, and Natasha N Kumar, and Adam V Benjafield, and William Y S Wang, and Brian J Morris
November 2006, Annals of human genetics,
Helen J L Speirs, and Ksenia Katyk, and Natasha N Kumar, and Adam V Benjafield, and William Y S Wang, and Brian J Morris
June 2015, Hypertension (Dallas, Tex. : 1979),
Helen J L Speirs, and Ksenia Katyk, and Natasha N Kumar, and Adam V Benjafield, and William Y S Wang, and Brian J Morris
November 2003, Clinical genetics,
Helen J L Speirs, and Ksenia Katyk, and Natasha N Kumar, and Adam V Benjafield, and William Y S Wang, and Brian J Morris
May 2013, Genetic testing and molecular biomarkers,
Helen J L Speirs, and Ksenia Katyk, and Natasha N Kumar, and Adam V Benjafield, and William Y S Wang, and Brian J Morris
May 1999, Clinical pharmacology and therapeutics,
Helen J L Speirs, and Ksenia Katyk, and Natasha N Kumar, and Adam V Benjafield, and William Y S Wang, and Brian J Morris
September 2004, Molecular pharmacology,
Helen J L Speirs, and Ksenia Katyk, and Natasha N Kumar, and Adam V Benjafield, and William Y S Wang, and Brian J Morris
March 2006, Molecular pharmacology,
Helen J L Speirs, and Ksenia Katyk, and Natasha N Kumar, and Adam V Benjafield, and William Y S Wang, and Brian J Morris
January 2012, International journal of hypertension,
Helen J L Speirs, and Ksenia Katyk, and Natasha N Kumar, and Adam V Benjafield, and William Y S Wang, and Brian J Morris
July 2013, European journal of heart failure,
Copied contents to your clipboard!